May 29th, 2026

The call highlighted clear operational progress: revenue growth, mid-single-digit comps at Journeys, a strong +7% quarter at Johnston & Murphy, gross margin expansion (up 30 bps), SG&A leverage and an upgraded full-year EPS and operating income outlook. Management also announced a sizable cost program and expects meaningful tariff refunds. Offsetting these positives are a continued adjusted operating loss, a pronounced Schuh banner decline (comp -9%) with a cautious U.K. outlook, multi-quarter license-exit headwinds (Levi’s), and a pressured Q2 with sales expected down 3%–4%. On balance, the operational momentum, raised guidance and structural cost initiatives outweigh the near-term headwinds, but the path to sustained profitability still depends on Schuh recovery, execution of cost savings, and macro stability.

Company Guidance

Genesco raised its fiscal 2027 outlook, tightening full‑year EPS to $2.00–$2.40 (up from prior guidance), with comparable sales estimated at ~1%–2% and total sales expected to be down 1% to flat (reflecting ~$30M of store‑closure sales loss and ~$30M of lost license revenue), adjusted operating income now forecast at approximately $34M–$40M (middle of the range most likely), gross margin up ~50–60 basis points, SG&A roughly flat to ~20 bps of deleverage (versus prior 10–30 bps deleverage), an assumed annual incremental tariff rate of 15% (tariff refund of ~$23M–$25M has been filed but is excluded from outlook), no incremental share repurchases (fiscal '27 average share count ~10.9M), and a full‑year tax rate of ~30% (with lower quarter‑to‑quarter rates — ~7%–8% in Q1–Q3 and a Q4 true‑up). For Q2 specifically they expect comps flat to slightly down, total sales down ~3%–4%, gross margin up ~50–70 bps, SG&A deleverage of ~60–80 bps, an operating loss in line with to slightly worse than last year and EPS about $0.20–$0.30 lower (Q2 called the most pressured quarter), with improvement weighted to the back half of the year (especially Q4).